Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Sep. 30, 2020
Current assets:    
Cash and cash equivalents $ 6,952 $ 12,162
Restricted cash 630 114
Accounts receivable 3,765 1,092
Short term investments (cost: 2021-$297,472; 2020-$0) 297,175 0
Prepaid expenses and other current assets 5,925 1,011
Total current assets 314,447 14,379
Non-current assets:    
Property and equipment, net 1,958 1,759
Investment in joint venture 200 200
Intangible assets, net 12,644 533
Goodwill 13,271 0
Operating right-of-use asset 654 737
Other non-current assets 220 107
Total assets 343,394 17,715
Current liabilities:    
Accounts payable and accrued expenses 4,446 776
Deferred revenue 4,654 3,973
Operating lease liability, current 431 430
Note payable 0 1,165
Total current liabilities 9,531 6,344
Non-current liabilities:    
Warrant liability 42,217 0
Operating lease liability, long term 222 291
Deferred tax liability 195 0
Total liabilities 52,165 6,635
Commitments and contingencies
Stockholders' Equity    
Preferred stock, $0.0001 par value, 2,000,000 shares authorized at September 30, 2021 and 2020. No shares issued and outstanding at September 30, 2021 and 2020. 0 0
Common stock, $0.0001 par value; 400,000,000 authorized; 70,096,401 and 25,268,848 shares issued at September 30, 2021 and 2020, respectively 7 3
Additional paid in capital 368,709 48,215
Accumulated other comprehensive loss (297) 0
Accumulated deficit (77,190) (37,138)
Total stockholders' equity 291,229 11,080
Total liabilities and (deficit) equity $ 343,394 $ 17,715